Healthcare - Biotechnology - NASDAQ - US
$ 4.19
-2.1 %
$ 249 M
Market Cap
-3.3
P/E
INCOME STATEMENT
0
REVENUE
-82.2 M
OPERATING INCOME
-73.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Pyxis Oncology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 2 M |
| Gross Profit | -2 M |
| Operating Expenses | 82.2 M |
| Operating Income | -82.2 M |
| Other Expenses | -8.41 M |
| Net Income | -73.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 2.0 | 1.8 | 1.3 | 0.4 | 0 |
| Gross Profit | (2.0) | (1.8) | (1.3) | (0.4) | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 82.2 | 123.5 | 69.7 | 12.9 | 2.9 |
| Selling, General and Administrative Expenses | 30.8 | 37.4 | 18.7 | 3.8 | 1.7 |
| Research and Development Expenses | 49.6 | 86.1 | 51.1 | 9.0 | 1.2 |
| Operating Income | (82.2) | (123.5) | (69.7) | (12.9) | (2.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | (2.8) | 0 | 0 | 0 |
| Total Other Income | 8.4 | 2.8 | (6.3) | 66 K | 0.1 |
| Pre-Tax Income | (73.8) | (120.7) | (76.0) | (12.8) | (2.8) |
| NET INCOME | |||||
| Tax Provision | 0 | (2.8) | 5.6 | 66 K | (0.1) |
| Net Income | (73.8) | (118.0) | (81.5) | (12.8) | (2.7) |
| EPS | 1.85 | 3.57 | 2.53 | 0.37 | 0.0777 |